These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36993520)
1. Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibiting moderate effect on normal stem cells growth. Alexanian A; Stoellinger H; De Araujo Farias V; Quinones-Hinojosa A Res Sq; 2023 Mar; ():. PubMed ID: 36993520 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth. Alexanian AR; Stoellinger HM; de Araujo Farias V; Quiñones-Hinojosa A Invest New Drugs; 2023 Jun; 41(3):371-375. PubMed ID: 37162706 [TBL] [Abstract][Full Text] [Related]
3. Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth. Alexanian AR; Brannon A Med Oncol; 2022 Apr; 39(5):86. PubMed ID: 35478054 [TBL] [Abstract][Full Text] [Related]
4. Specific combinations of the chromatin-modifying enzyme modulators significantly attenuate glioblastoma cell proliferation and viability while exerting minimal effect on normal adult stem cells growth. Alexanian AR; Huang YW Tumour Biol; 2015 Nov; 36(11):9067-72. PubMed ID: 26084611 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells. Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136 [TBL] [Abstract][Full Text] [Related]
7. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. Staberg M; Michaelsen SR; Rasmussen RD; Villingshøj M; Poulsen HS; Hamerlik P Cell Oncol (Dordr); 2017 Feb; 40(1):21-32. PubMed ID: 27766591 [TBL] [Abstract][Full Text] [Related]
9. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related]
10. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691 [TBL] [Abstract][Full Text] [Related]
11. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755 [TBL] [Abstract][Full Text] [Related]
12. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR. Tutak I; Ozdil B; Uysal A Pathol Res Pract; 2022 Nov; 239():154145. PubMed ID: 36240647 [TBL] [Abstract][Full Text] [Related]
13. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219 [TBL] [Abstract][Full Text] [Related]
14. An update on the epigenetics of glioblastomas. Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630 [TBL] [Abstract][Full Text] [Related]
20. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response. Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]